MARALEE WAGNER: Open Payments
NPI 1902370711 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,178 in 75 payments from 13 companies in 2025. Trend: 2023 $22 · 2024 $78 · 2025 $1,178
Food & beverage: $1,094Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $353 |
| ABBVIE INC. | 18 | $311 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $153 |
| Phathom Pharmaceuticals, Inc. | 7 | $86 |
| Celltrion USA Inc. | 4 | $66 |
| PFIZER INC. | 2 | $58 |
| Madrigal Pharmaceuticals | 2 | $35 |
| Novo Nordisk Inc | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| GENZYME CORPORATION | 1 | $19 |
Products named: TREMFYA, RINVOQ, XIFAXAN, VOQUEZNA, CREON, VEGZELMA, VELSIPITY, LINZESS.
Industry payments across AZ — which companies pay providers there.
